Marsh & McLennan Companies, Inc. (MRSH)

NYSE · Financials · Insurance Brokers
By Alex · Tickerpine
$188.86
-2.39 (-1.25%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$90.13B
P/E (TTM)
23.4
Forward P/E
16.6
EPS (TTM)
$8.08
ROE
25.90%
Profit Margin
14.24%
Revenue Growth
6.20%
Dividend Yield
2.07%
Beta
0.58
52W High
$213.80
52W Low
$156.60
Analyst Target
$205.52
What would an investment in MRSH be worth today?
Run MRSH through our free historical return calculator.
Calculate MRSH returns →

MRSH historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year -6.4% -6.4% $936
3 years +1.8% +0.6% $1,018
5 years +29.9% +5.4% $1,299
10 years +231% +12.7% $3,306
20 years +1,027% +12.9% $11,271
Since 1985 +10,682% +11.9% $107,815

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in MRSH.

MRSH annual returns by year

2026 YTD +3.4%
2025 -11.3%
2024 +13.7%
2023 +16.1%
2022 -3.5%
2021 +50.8%
2020 +6.9%
2019 +42.3%
2018 -0.1%
2017 +22.7%

Insider activity in MRSH

MRSH's own executives and directors have made 0 open-market purchases ($0) and 5 sales ($7.5M) in the last 90 days, per SEC Form 4 filings. Most recent: Aug 6, 2026.

Aug 6, 2026Jones John Jude Chief Marketing Officer Sell $1.2M
Jul 29, 2026Beswick Paul SVP, Chief Information Officer Sell $141,174
Jul 28, 2026South Martin Chief Client Officer Sell $1.3M
Jul 23, 2026Yates Lloyd M Director Sell $2.1M
Jun 2, 2026Doyle John Q President and CEO Sell $2.7M

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies, Inc., a professional services company, provides advisory services and insurance solutions to clients in the areas of risk, strategy, and people worldwide. The company operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk management, insurance broking, insurance program management, risk consulting, analytical modeling, and alternative risk financing services. This segment also offers insurance and reinsurance broking, strategic advisory and actuarial services, and analytics solutions. It serves businesses, public entities, insurance companies, associations, professional services organizations, and private clients. The Consulting segment provides health, wealth and career advice, solutions and products; and specialized management, strategic, economic, and brand consulting services. Marsh & McLennan Companies, Inc. was founded in 1871 and is headquartered in New York, New York.

Company website ↗

MRSH Key Statistics

Previous Close$191.25P/E Ratio23.4
Market Cap$90.13BPEG Ratio1.83
Revenue (TTM)$27.95BROE25.90%
Gross Margin43.99%ROA7.24%
Debt / Equity145.0Employees95,000

MRSH in plain English

MRSH stock: frequently asked questions

What is Marsh & McLennan Companies, Inc.'s stock price today?

Marsh & McLennan Companies, Inc. (MRSH) last traded at $188.86 on the NYSE. Over the past 52 weeks the stock has traded between $156.60 and $213.80.

How much would $1,000 invested in MRSH 10 years ago be worth today?

A $1,000 investment in Marsh & McLennan Companies, Inc. made 10 years ago would be worth about $3,306 today (dividends reinvested) — a total return of 231%, or 12.7% per year.

Does MRSH pay a dividend?

Yes. Marsh & McLennan Companies, Inc. currently pays a dividend yielding about 2.07% per year at today's share price.

What is MRSH's P/E ratio?

MRSH trades at a trailing price-to-earnings ratio of 23.4, and 16.6 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

What is Marsh & McLennan Companies, Inc.'s ticker symbol?

Marsh & McLennan Companies, Inc. trades under the ticker symbol MRSH on the NYSE.

Compare MRSH with peers

MRSH vs BRK-BBerkshire Hathaway Inc. $510.00 MRSH vs JPMJP Morgan Chase & Co. $365.18 MRSH vs VVisa Inc. $359.42 MRSH vs MAMastercard Incorporated $559.73 MRSH vs BACBank of America Corporation $64.81

Data last refreshed from public sources. Figures may be delayed. Not investment advice.